Andrea Messori Author
Subjects of specialization
Affiliation
Implantable cardioverter-defibrillators, Myocardial infarction
ESTAV Toscana Centro, Regional Health Service, Italy
A few studies have previously been focused on the sources of variability in patients receiving primary prevention with implantable cardioverter-defibrillators (ICDs) after myocardial infarction (MI). While time to implantation after MI showed no influence on outcomes, the extent of between-studies variability and the presence of any temporal trend across different calendar years have not been investigated thus far.
Case Report Subscription
Author(s): Andrea Messori, Sabrina Trippoli, DarioMaratea, Valeria Fadda and Claudio Marinai
Prevention of Venous Thromboembolism in Major Orthopedic Surgery: Bayesian Network Meta-Analysis of 21 Randomized Trials Evaluating Unfractionated Heparins, LowMolecular Weight Heparins, and New Oral Anticoagulants
Objective: In major orthopedic surgery, the prevention of venous thromboembolism has been based, over the past decades, on unfractionated heparins (UFHs), then on low-molecular weight heparins (LMWHs) and, more recently, on new oral anticoagulants (NOACs). To summarize the comparative effectiveness of UFHs, LMWHs, and NOACs in this clinical indication, we applied Bayesian network meta-analysis to the clinical material (randomized studies) published in two p... view moreĀ»